For the quarter ending 2026-03-31, BODYW had -$2,426K decrease in cash & cash equivalents over the period. -$1,723K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
| Net income (loss) | 2,286 | 5,219 | -8,079 |
| Impairment of goodwill | - | 0 | - |
| Depreciation and amortization expense | 2,228 | 1,891 | 6,789 |
| Amortization of content assets | 1,369 | 1,929 | 6,945 |
| Provision for inventory | 595 | 235 | 1,256 |
| Realized losses on hedging derivative financial instruments | - | 0 | 0 |
| Change in fair value of warrant liabilities | 191 | 2,087 | -107 |
| Equity-based compensation | 1,118 | 871 | 4,744 |
| Amortization of debt issuance costs | 178 | 166 | 1,280 |
| Paid-in-kind interest expense | 0 | 0 | 218 |
| Loss on debt extinguishment | - | 0 | -2,166 |
| Change in lease assets | 199 | 278 | 1,161 |
| Inventory | 1,315 | -1,503 | -3,899 |
| Content assets | 1,006 | 693 | 2,294 |
| Prepaid expenses | 129 | 2,507 | -4,718 |
| Other assets | -294 | -2,386 | -23,378 |
| Accounts payable | 944 | 1,043 | -5,234 |
| Accrued expenses | -4,188 | -4,918 | -1,844 |
| Deferred revenue | -2,247 | -6,569 | -17,434 |
| Other liabilities | -1,556 | 2,062 | -4,795 |
| Net cash (used in) provided by operating activities | -1,039 | 4,983 | 16,767 |
| Purchase of property and equipment | 684 | 701 | 3,698 |
| Net cash used in investing activities | -684 | -701 | -3,698 |
| Proceeds from exercise of stock options | 14 | 457 | 67 |
| Debt borrowings | - | 0 | 25,000 |
| Debt repayments | 0 | 0 | 22,582 |
| Proceeds from issuance of common shares in the employee stock purchase plan | - | 65 | 78 |
| Tax withholding payments for vesting of restricted stock | 372 | 3 | 271 |
| Payment of debt issuance costs | 250 | 0 | 1,781 |
| Net cash used in financing activities | -608 | 519 | 511 |
| Effect of exchange rates on cash, cash equivalents, and restricted cash | -95 | 267 | 182 |
| Net decrease in cash, cash equivalents, and restricted cash | -2,426 | 5,068 | 13,762 |
| Cash, cash equivalents and restricted cash, beginning of period | 39,017 | 33,949 | 20,187 |
| Cash, cash equivalents, and restricted cash, end of period | 36,591 | 39,017 | 33,949 |
Beachbody Company, Inc. (BODYW)
Beachbody Company, Inc. (BODYW)